tiprankstipranks
Urogen Pharma (URGN)
:URGN
US Market

Urogen Pharma (URGN) Income Statement

Compare
460 Followers

Urogen Pharma Income Statement

Last quarter (Q3 2024), Urogen Pharma's total revenue was $25.20M, an increase of 20.87% from the same quarter last year. In Q3, Urogen Pharma's net income was $-23.67M. See Urogen Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 82.71M$ 64.36M$ 48.04M$ 11.80M$ 18.00K
Gross Profit
$ 73.35M$ 56.70M$ 42.88M$ 10.79M$ 18.00K
Operating Expenses
$ 138.89M$ 135.74M$ 135.18M$ 137.53M$ 109.50M
Depreciation and Amortization
$ 1.71M$ 1.82M$ 1.77M$ 2.04M$ 1.32M
EBITDA
$ -63.83M$ -78.03M$ -90.15M$ -122.71M$ -108.15M
Operating Income
$ -65.54M$ -79.04M$ -92.29M$ -126.74M$ -109.48M
Other Income/Expenses
$ -32.79M$ -28.99M$ -17.08M$ 1.63M$ 4.33M
Pretax Income
$ -98.32M$ -108.03M$ -109.37M$ -125.11M$ -105.15M
Net Income
$ -102.24M$ -109.16M$ -110.82M$ -128.48M$ -100.53M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -3.55$ -4.79$ -4.96$ -5.90$ -4.90
Diluted EPS
$ -3.55$ -4.79$ -4.96$ -5.90$ -4.90
Weighted Average Shares Outstanding
28.83M 22.81M 22.35M 21.78M 20.53M
Weighted Average Shares Outstanding (Diluted)
28.83M 22.81M 22.35M 21.78M 20.53M
Currency in USD

Urogen Pharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis